Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The aim of the study is to investigate long-term health benefits of early vitamin D supplementation with a dose ensuring effective concentration of 25-OHD.

Source: Overall aims and research questions. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI): study design and methods of a randomised controlled double-blinded intervention study

Source: Article title.

Safety was ensured by performing a pilot study for the proposed project: 113 children were randomised into three groups receiving vitamin D3 doses of 10, 30 and 40 μg daily for 3 months [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI): study design and methods of a randomised controlled double-blinded intervention study

Study design awaiting verification · BMC Pediatrics · 2017

Original publication title

Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI): study design and methods of a randomised controlled double-blinded intervention study

Otto Helve; Heli Viljakainen; Elisa Holmlund-Suila; Jenni Rosendahl; Helena Hauta-alus; Maria Enlund-Cerullo; Saara Valkama; Kati Heinonen; Katri Räikkönen; Timo Hytinantti; Outi Mäkitie; Sture Andersson

© The Author(s). 2017

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What background does the paper provide?

Vitamin D is important for bone mass accrual during growth. Additionally, it is considered a requirement for a multitude of processes associated with, for example, the development of immunity. Many countries apply vitamin D supplementation strategies in infants, but the guidelines are not based on scientific evidence and aim at prevention of rickets. It remains unclear whether the recommended doses are sufficient for the wide array of other effects of vitamin D. The VIDI trial performed in Finland is the first large randomised controlled study for evaluation of the effects of different vitamin D supplemental doses in infancy on:

  1. bone strength

  2. infections and immunity

  3. allergy, atopy and asthma

  4. cognitive development

  5. genetic regulation of mineral homeostasis

Source: Background

Abstract: Methods/Design

VIDI, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2 weeks to 24 months. Participants, recruited at Helsinki Maternity Hospital, are randomised to receive daily either 10 μg (400 IU) or 30 μg (1 200 IU) of vitamin D3 supplementation. Both groups are assessed at 6 months of age for calcium homeostasis, and at 12 and 24 months of age for parameters associated with bone strength, growth, developmental milestones, infections, immunity, atopy-related diseases, and genetic factors involved in these functions.

Source: Methods/Design

Abstract: Discussion

The study enables evaluation of short and long term effects of supplemental vitamin D on growth, immune functions and skeletal and developmental parameters in infants, and the effects of genetic factors therein. The results enable institution of evidence-based guidelines for vitamin D supplementation in infancy.

Source: Discussion

Abstract: Electronic supplementary material

The online version of this article (doi:10.1186/s12887-017-0845-5) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material
Authors’ abstract

Background

Vitamin D is important for bone mass accrual during growth. Additionally, it is considered a requirement for a multitude of processes associated with, for example, the development of immunity. Many countries apply vitamin D supplementation strategies in infants, but the guidelines are not based on scientific evidence and aim at prevention of rickets. It remains unclear whether the recommended doses are sufficient for the wide array of other effects of vitamin D. The VIDI trial performed in Finland is the first large randomised controlled study for evaluation of the effects of different vitamin D supplemental doses in infancy on:

  1. bone strength

  2. infections and immunity

  3. allergy, atopy and asthma

  4. cognitive development

  5. genetic regulation of mineral homeostasis

Methods/Design

VIDI, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2 weeks to 24 months. Participants, recruited at Helsinki Maternity Hospital, are randomised to receive daily either 10 μg (400 IU) or 30 μg (1 200 IU) of vitamin D3 supplementation. Both groups are assessed at 6 months of age for calcium homeostasis, and at 12 and 24 months of age for parameters associated with bone strength, growth, developmental milestones, infections, immunity, atopy-related diseases, and genetic factors involved in these functions.

Discussion

The study enables evaluation of short and long term effects of supplemental vitamin D on growth, immune functions and skeletal and developmental parameters in infants, and the effects of genetic factors therein. The results enable institution of evidence-based guidelines for vitamin D supplementation in infancy.

Trial registration

ClinicalTrials.gov, NCT01723852, registration date 6.11.2012.

Electronic supplementary material

The online version of this article (doi:10.1186/s12887-017-0845-5) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI): study design and methods of a randomised controlled double-blinded intervention study

Otto Helve; Heli Viljakainen; Elisa Holmlund-Suila; Jenni Rosendahl; Helena Hauta-alus; Maria Enlund-Cerullo; Saara Valkama; Kati Heinonen; Katri Räikkönen; Timo Hytinantti; Outi Mäkitie; Sture Andersson

BMC Pediatrics · 2017

© The Author(s). 2017https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.The Governmental Subsidy for Clinical ResearchFoundation for Pediatric ResearchFinska LäkaresällskapetFolkhälsan Research FoundationSigrid Juselius FoundationEmil Aaltonen Foundationhttp://dx.doi.org/10.13039/100010119Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns MinnePäivikki and Sakari Sohlberg Foundationhttp://dx.doi.org/10.13039/100008723Suomen Lääketieteen Säätiö

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:38:07.474061+00:00

DOI: 10.1186/s12887-017-0845-5 · PMC5372327